The Huxley Morton Podcast
Helping small businesses execute their success with Robert Nauman| Ep 15

Helping small businesses execute their success with Robert Nauman| Ep 15

October 13, 2021

Series 3 Ep.15 Robert Nauman Managing Director at JBS Ventures.

Assisting leaders and entrepreneurs execute their vision in Life Sciences and Health IT.

That’s what this weeks guest is all about.

He first got into the pharma industry after his father suggested it was a good place to earn some money.

20 Years’s on, and he’s still active. Having spent time with some of the industry giants such as GSK, he is now using his ability to solve key business issues and create organizational change that maximizes revenue and minimize cost.

 

It‘s all about the People!! Rachel Jones on Behavioural Change & Patient Engagement | Ep14

It‘s all about the People!! Rachel Jones on Behavioural Change & Patient Engagement | Ep14

October 6, 2021

For Rachel Jones failure was not an option when she lost her mother and was made redundant in a matter of days.

A single mum of two children, Rachel boxed up her emotions and landed her dream project working on Patient engagement. Through her experience, she then went on to Co-found Swii.ch Health a successful boutique agency specialising in digital, behavioural change and patient Engagement.

Rachel shares her story and tips that have helped her to be successful and happy in her career.

Stuart opens up about his darkest moments, his successes and his failures in Entrepreneurship | Ep13

Stuart opens up about his darkest moments, his successes and his failures in Entrepreneurship | Ep13

September 29, 2021

Series 3 Ep.13 – Stuart McCully Founder of Phoenix RWR and Co-Founder of Real World Research.

Stuart opens up about his darkest moments, his successes and his failures in Entrepreneurship. We also discuss the topic of Mental health and why there's such a stigma around talking about certain topics.

Phoenix-RWR is a consulting firm that specializes in providing regulatory compliance solutions and regulatory intelligence for real-world research studies, such as non-interventional studies.

 

Series 3, Episode 12 Panel show special! Have we had Patient Centricity all wrong?

Series 3, Episode 12 Panel show special! Have we had Patient Centricity all wrong?

September 22, 2021

Series 3, Episode 12 Panel show special!

This week we have several returning guests for a special edition panel show where we discuss ‘What it takes to Change an Industry’

Our panel of experts include Scott Stout CEO at Medvector - Finance Expert.

Scott’s previous appearance on the show - https://youtu.be/dC5g8_f42pc

Ted Barduson COO at Medvector – Healthcare and physicians practice Expert.

Craig Lipset Founder at Clinical Innovation Partner – Decentralized Trials & Innovation Expert.

Craig’s previous appearance on the show - https://youtu.be/4Oz0KZkc5-k

Adam Walker – Healthcare & Biometrics Expert.

Adam’s previous appearance on the show - https://youtu.be/g-88Wd6miEk

All of our guests form part of the MedVector Clinical Trials team that is streamlining the Clinical Research Industry.

We discuss the following topics:

What does it take to change an industry?

New people, new companies, acceptance of established companies innovative ideas.

The pandemic and its impact on:

- The explosion, acceptance of telemedicine.

- The impact on the DCT marketplace.

- The awareness of clinical trials and how patient-centricity is linked to the guidance of physicians.

- The financial impact on doctors individual and practice revenues and profits.

What is Medvector? And what is it not?

And WHY RIGHT NOW?

Series 3 Ep.11 Christina DiArcangelo CEO and Founder of Affinity Bio partners

Series 3 Ep.11 Christina DiArcangelo CEO and Founder of Affinity Bio partners

September 15, 2021

This week we get under the skin of entrepreneur and CEO Christina DiArcangelo.

With more than two decades of experience in the Medical cannabis, biotechnology, pharmaceutical, nutraceutical, and medical device industries.

Christina is a clinical research pioneer, contracts negotiator, Opinion Columnist for CEO WorldBiz, and even has her own podcast, I am Christina DiArcangelo!

This is definitely one of our most honest and open conversations to date. Christina shares her story of experiencing domestic violence to filming and staring in Season 2 of the “Four Days to Save the World” TV Series that will be released on Earth Day 2022.

Series 3 Ep.10 Mike Keens- Executive Vice President, Operations. Don’t be afraid to share your opinion.

Series 3 Ep.10 Mike Keens- Executive Vice President, Operations. Don’t be afraid to share your opinion.

September 8, 2021

With over 20 years of experience in Clinical operations, Mike shares his story and how he transitioned to a new job at the height of the pandemic.

Mike is a keen advocate for decentralized trials and has several predictions about the Clinical development field to share.

Series 3 Ep.9 Jo Bhakdi CEO and Founder of Quantgene- Extending life with Data

Series 3 Ep.9 Jo Bhakdi CEO and Founder of Quantgene- Extending life with Data

September 1, 2021

This week we speak to Jo Bhakdi Founder and CEO of Quantgene.

Jo and the team at Quantgene are about to launch Serenity, the worlds first medical solution to protect against multiple cancers through early detection and prevention.

Jo combines the perfect blend of economics and science to become a real disrupter in the industry.

In today’s episode, we cover

  • Who is Jo Bhakdi and what is his background?
  • What does Quantgene do?
  • Jo’s vision is what he calls “10 in 10” to extend the healthy human lifespan by a decade within the next decade.
  • How Quantgene helped the film industry get back on its feet by providing on-site coronavirus testing and results within a 24hrs window.
  • Answers to our quick-fire questions.
Series 3 Ep8. Scientist by day and Chef by night with Vidya Maharaj

Series 3 Ep8. Scientist by day and Chef by night with Vidya Maharaj

August 25, 2021

This week we speak to Vidya Maharaj, Vice president of Clinical Operations and Development at Regenerative Outcomes.

Not only does she have an extremely successful career in pharmaceuticals which has seen her rapidly climb through the ranks. Vidya is also executive Chef at one of Miami's hottest beachfront restaurants. 

Find out how she juggles two extremely successful careers and everything else in between.

 

Series 3 Ep7- Non-Invasive detection and diagnosis of breast cancer with Elizabeth Cormier-May

Series 3 Ep7- Non-Invasive detection and diagnosis of breast cancer with Elizabeth Cormier-May

August 18, 2021

Radically improving the detection, diagnosis and treatment of women’s health-related disease.

Elizabeth Cormier-May and the team Mammogen are integrating data, science and the lived experiences from patients that they serve into the ongoing product development efforts related to their flagship breast cancer program.

Mammogen is a female-led biotechnology company focused on meaningfully improving the detection, diagnosis and treatment of women's health-related diseases, and creating an end-to-never-end community for women around the world.

 

Mammogen is centred around its proprietary genTRU™ liquid biopsy platform. The company's flagship genTRU breast™ program leverages novel messenger RNA (mRNA) technology to non-invasively detect and diagnose breast cancer.

Mammogen's core technology is a non-invasive screening solution intended for all women, but particularly for the under-40 population who aren't eligible for annual mammography and the 55+ population who are only recommended for mammography every other year.

 

Series 3. Ep6 - Supporting the Rare Disease community with Alex Evans, CEO at RAREiTi

Series 3. Ep6 - Supporting the Rare Disease community with Alex Evans, CEO at RAREiTi

August 11, 2021

With a background in nursing as well as in the pharmaceutical industry, Alex Evans​ brings a wealth of experience and expertise to her role as CEO of RAREiTi.

Tune in to hear how their managed access and medicines management programs offer support beyond therapy, combining care solutions that are specifically developed, carefully measured, and designed to improve outcomes. 

There’s tremendous potential here to help rare disease drug developers increase their success rates locally and globally, and at the same time help doctors and patients gain access to new, and often life-changing, medicines.

A heart-warming episode with stories of patients this amazing resource has helped.

Podbean App

Play this podcast on Podbean App